LEUKAEMIA MICROENVIRONMENT & HIGH RISK CHILDHOOD LEUKAEMIA
With
Associate Professor Laurence Cheung
Curtin University
& Research Lead, Curtin Medical Research Institute,
Western Australia &
Research Lead,
The Kids Research Institute,
Western Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | February 2026
Associate Professor Laurence Cheung is an exemplary pharmacist-scientist whose research is focused on improving outcomes in children with high-risk leukaemia.
He obtained his Bachelor of Pharmacy degree with First Class Honours from the Curtin University in 2000 and have been a registered pharmacist since 2001. In 2014, he completed the PhD studies at The Kids Research Institute Australia (The Kids) in the area of haematopoiesis and paediatric leukaemia.
He is now an Associate Professor at the Curtin Medical School as well as Curtin Medical Research Institute, and a Co-head of the Leukaemia Translational Research Laboratory at The Kids.
He has attracted over $8.7 million in research funding, including 16 awards as CIA (over $6.1 million). Assoc Prof Cheung was named the 2019 Cancer Council of WA Early Career Cancer Researcher of the Year and received the STEM Early Career Research Award at Curtin University in 2019.
Assoc Prof Cheung enjoys nurturing and motivating the next generation scientists and HDR students and he believes that the true success is about influencing others to achieve their own greatness.
He has supervised two PhD and one Masters students to completion, and is currently supervising 4 PhD students as a Primary Supervisor. In 2023, Assoc Prof Cheung received the Faulty of Health Sciences Teaching Excellence Individual Award for Honours, Postgraduate, or HDR supervision at Curtin University.
Funding sources include: Toby for Childhood Cancer, Cancer Council Western Australia, WA Government
Source: Supplied and adapted
https://orcid.org/0000-0001-6298-5288
-
Professor Sandy Middleton
NURSING RESEARCH INSTITUTE, ST VINCENT’S HEALTH NETWORK SYDNEY, ST VINCENT’S HOSPITAL MELBOURNE AND AUSTRALIAN CATHOLIC UNIVERSITY
NEW SOUTH WALES, AUSTRALIA -
Ocular disease and early onset myopia
Dr Mountford has successfully established Western Australia’s first and only ocular genetic screening platform using zebrafish and utilises this model to help elucidate some of the complex gene-environment interactions responsible for the development of myopia.
-
Earlier identification and early intervention for children who are deaf or hard of hearing
As Director of NextSense Institute, Professor Leigh is responsible for leading the not-for-profit organisation’s world-class research and education programs and facilities. He has held a variety of positions in the education of children who are deaf or hard of hearing before entering academia. He holds a degree in Special Education from Griffith University, a Master of Science (Speech and Hearing) from Washington University and a PhD in Special Education from Monash University. In 2001, he was made a Fellow of the Australian College of Educators and in 2014, he was invested as an Officer in the Order of Australia (AO) for distinguished services to the deaf and hard of hearing community.
